Hereditary Hemochromatosis
Introduction
Hereditary Hemochromatosis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<table class="infobox infobox-gene"> [^2]
<tr> [^3]
<th class="infobox-header" colspan="2">Hereditary Hemochromatosis</th> [^4]
</tr> [^5]
<tr> [^6]
<td class="label">Gene</td> [^7]
<td>HFE (primary), HJV, HAMP, TFR2, SLC40A1</td> [^8]
</tr> [^9]
<tr> [^10]
<td class="label">Inheritance</td> [^11]
<td>Autosomal Recessive</td> [^12]
</tr> [^13]
<tr> [^14]
<td class="label">Chromosome</td> [^15]
<td>6p21.3 (HFE)</td> [^16]
</tr> [^17]
<tr> [^18]
<td class="label">OMIM</td>
<td>235200 (HFE-related)</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>1 in 200-400 (C282Y homozygotes)</td>
</tr>
</table>
Overview
Hereditary hemochromatosis (HH) is a group of autosomal recessive genetic disorders characterized by excessive iron accumulation in tissues throughout the body. The most common form is HFE-related hemochromatosis, caused by mutations in the HFE gene on chromosome 6p21.3. This condition leads to progressive iron overload in the liver, heart, pancreas, joints, and central nervous system, potentially causing severe organ damage if left untreated.
Genetics and Pathophysiology
HFE Gene Mutations
...Hereditary Hemochromatosis
Introduction
Hereditary Hemochromatosis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<table class="infobox infobox-gene"> [^2]
<tr> [^3]
<th class="infobox-header" colspan="2">Hereditary Hemochromatosis</th> [^4]
</tr> [^5]
<tr> [^6]
<td class="label">Gene</td> [^7]
<td>HFE (primary), HJV, HAMP, TFR2, SLC40A1</td> [^8]
</tr> [^9]
<tr> [^10]
<td class="label">Inheritance</td> [^11]
<td>Autosomal Recessive</td> [^12]
</tr> [^13]
<tr> [^14]
<td class="label">Chromosome</td> [^15]
<td>6p21.3 (HFE)</td> [^16]
</tr> [^17]
<tr> [^18]
<td class="label">OMIM</td>
<td>235200 (HFE-related)</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>1 in 200-400 (C282Y homozygotes)</td>
</tr>
</table>
Overview
Hereditary hemochromatosis (HH) is a group of autosomal recessive genetic disorders characterized by excessive iron accumulation in tissues throughout the body. The most common form is HFE-related hemochromatosis, caused by mutations in the HFE gene on chromosome 6p21.3. This condition leads to progressive iron overload in the liver, heart, pancreas, joints, and central nervous system, potentially causing severe organ damage if left untreated.
Genetics and Pathophysiology
HFE Gene Mutations
The HFE gene encodes the hereditary hemochromatosis protein, which regulates hepcidin expression—the key hormone controlling iron absorption in the intestine.[^1] The two most common pathogenic variants are:
- C282Y (p.Cys282Tyr): The most frequent mutation, resulting in a cysteine-to-tyrosine substitution at position 282. Homozygotes for C282Y have significantly elevated transferrin saturation and ferritin levels.
- H63D (p.His63Asp): A milder variant that may contribute to iron overload when compound heterozygous with C282Y or in combination with other genetic or environmental factors.
In hereditary hemochromatosis, the normal feedback mechanism linking body iron stores to intestinal iron absorption is disrupted. Normally, increased hepatic iron stores stimulate hepcidin production, which reduces intestinal iron absorption. In HH, this regulatory loop fails, leading to uncontrolled iron absorption from the diet.
The excess iron accumulates primarily in:
- Liver: Hepatocytes and Kupffer cells
- Heart: Cardiac myocytes
- Pancreas: Beta cells of the Islets of Langerhans
- Pituitary gland: Leading to endocrine dysfunction
- Brain: Basal ganglia, substantia nigra, and cortical regions
Neurological Manifestations
Movement Disorders
Iron deposition in the basal ganglia can lead to Parkinsonian features:
- Resting tremor: Typically asymmetric
- Rigidity: Cogwheel-type rigidity
- Bradykinesia: Slowed movements
- Postural instability: Balance difficulties
These symptoms may be misdiagnosed as idiopathic Parkinson's Disease, but typically lack the classic Lewy body pathology.
Cognitive Impairment and Dementia
Iron accumulation in brain parenchyma is associated with:
- Executive dysfunction
- Memory impairment
- Behavioral changes
- Progressive cognitive decline resembling Alzheimer's Disease or Frontotemporal Dementia
Other Neurological Complications
- Cerebellar ataxia: Iron deposition in the cerebellum
- Peripheral neuropathy: Sensorimotor neuropathy
- Hypogonadotropic hypogonadism: Pituitary involvement
- Diabetes insipidus: Hypothalamic-pituitary axis dysfunction
Diagnosis
Biochemical Markers
- Transferrin saturation: >45% is suggestive (elevated)
- Serum ferritin: Elevated (>200 ng/mL in women, >300 ng/mL in men)
- Serum iron: Elevated
- Total iron-binding capacity (TIBC): Decreased
Genetic Testing
- HFE gene sequencing for C282Y, H63D, S65C variants
- Extended genetic testing for non-HFE hemochromatosis genes (HJV, HAMP, TFR2, SLC40A1)
Neuroimaging
- MRI brain: T2-weighted hypointensity in basal ganglia, substantia nigra, and cerebellum ("iron deposition pattern")
- Quantitative susceptibility mapping (QSM): Quantifies brain iron levels
- FDG-PET: May show hypometabolism in affected regions
Treatment
Iron Reduction Therapy
- Phlebotomy: Weekly phlebotomy (500 mL) until ferritin <50 ng/mL, then maintenance therapy
- Iron chelation: Deferoxamine, deferasirox, or deferiprone for patients who cannot undergo phlebotomy
Neurological Symptom Management
- Dopaminergic medications for parkinsonian symptoms
- Multidisciplinary approach involving neurology, hepatology, and endocrinology
- Physical and occupational therapy
Monitoring
- Regular monitoring of ferritin, transferrin saturation, and liver function
- Annual neurological assessment for early detection of movement disorders
- Cardiac MRI and echocardiography for iron overload cardiomyopathy
Relationship to Neurodegenerative Diseases
Alzheimer's Disease
Some studies suggest that iron overload may accelerate Alzheimer's Disease pathogenesis through:
- Increased oxidative stress
- [Amyloid-Beta](/proteins/amyloid-beta) aggregation enhancement
- [Tau](/proteins/tau) phosphorylation promotion
- Neuronal iron dysregulation
Parkinson's Disease
Iron accumulation in the substantia nigra is a hallmark of Parkinson's Disease. Patients with hereditary hemochromatosis may have an increased risk of parkinsonian symptoms, and MRI findings in HH can resemble those seen in PD.
Amyotrophic Lateral Sclerosis
Elevated iron levels have been reported in ALS patients, and dysregulated iron metabolism may contribute to motor neuron degeneration. The relationship between HH and ALS remains an active area of research.
See Also
- [Iron Metabolism](/mechanisms/iron-metabolism-neurodegeneration)
- [Neurodegeneration](/diseases/neurodegeneration)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Movement Disorders](/mechanisms/movement-disorders)
- [Oxidative Stress](/mechanisms/oxidative-stress)
External Links
- [National Hemochromatosis Foundation](https://www.hemochromatosis.org/)
- [NIH - Hereditary Hemochromatosis](https://www.niddk.nih.gov/health-information/liver-disease/hereditary-hemochromatosis)
- [Genetics Home Reference - HFE](https://ghr.nlm.nih.gov/gene/HFE)
- [OMIM - Hereditary Hemochromatosis](https://www.omim.org/entry/235200)
Background
The study of Hereditary Hemochromatosis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research (2024-2026)
This section highlights recent publications relevant to this disease.
- [Incorrect Genotyping in a Hemochromatosis Patient Heterozygous for HFE C282Y and Q283P Variants.](https://pubmed.ncbi.nlm.nih.gov/41413898/) (2026 Apr) - International journal of laboratory hematology
- [C282Y Homozygosity Increases Erythrocyte Turnover and Decreases HbA1c-A Population-Based Study.](https://pubmed.ncbi.nlm.nih.gov/41828626/) (2026 Mar 5) - International journal of molecular sciences
- [Clinical evolution of atypical pyoderma gangrenosum in a patient with hemochromatosis.](https://pubmed.ncbi.nlm.nih.gov/41762618/) (2026 Mar 2) - Journal of osteopathic medicine
- [Iron Storage Disease-Associated Retinal Degeneration in a Baird's Tapir (Tapirus bairdii).](https://pubmed.ncbi.nlm.nih.gov/41787683/) (2026 Mar) - Veterinary ophthalmology
- [Neuroprotection From Intracerebral Hemorrhage Following Pharmacological Inhibition of GSK3β Depends on HFE Gene Status.](https://pubmed.ncbi.nlm.nih.gov/41772831/) (2026 Mar) - Journal of neurochemistry
Allen Brain Atlas Resources
- [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
- [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
- [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
- [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data
References
[^18]: [Reference missing - citation needed]
[^17]: [Reference missing - citation needed]
[^16]: [Reference missing - citation needed]
[^15]: [Reference missing - citation needed]
[^14]: [Reference missing - citation needed]
[^13]: [Reference missing - citation needed]
[^12]: [Reference missing - citation needed]
[^11]: [Reference missing - citation needed]
[^10]: [Reference missing - citation needed]
[^9]: [Reference missing - citation needed]
[^8]: [Reference missing - citation needed]
[^7]: [Reference missing - citation needed]
[^6]: [Reference missing - citation needed]
[^5]: [Reference missing - citation needed]
[^4]: [Reference missing - citation needed]
[^3]: [Reference missing - citation needed]
[^2]: [Reference missing - citation needed]
[^1]: [Reference missing - citation needed]